Travere Therapeutics (TVTX) PT Lowered to $43 at BMO Capital

March 2, 2021 9:18 AM EST
Get Alerts TVTX Hot Sheet
Price: $25.61 +1.43%

Rating Summary:
    1 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 17 | Down: 14 | New: 42
Trade Now! 
Join SI Premium – FREE
BMO Capital analyst Kim Do lowered the price target on Travere Therapeutics (NASDAQ: TVTX) to $43.00 (from $48.00) while maintaining a Outperform rating.

You May Also Be Interested In

Related Categories

Analyst PT Change